fenofibrate has been researched along with Mouth Neoplasms in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate is a clinical lipid-lowering agent and an effective anticancer drug." | 1.43 | Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer. ( Chang, NW; Chiu, CF; Huang, YP; Jan, CI; Liu, CJ; Tsai, MH, 2016) |
| "0." | 1.37 | Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model. ( Chang, NW; Chiu, CF; Chu, PY; Hsu, HT; Lin, C; Tsai, MH; Yeh, CM; Yeh, KT, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, TR | 1 |
| Yu, CC | 1 |
| Chao, SC | 1 |
| Huang, CC | 1 |
| Liao, YW | 1 |
| Hsieh, PL | 1 |
| Yu, CH | 1 |
| Lin, SS | 1 |
| Tsai, SC | 1 |
| Tsai, MH | 3 |
| Chiu, CF | 3 |
| Lu, CC | 1 |
| Kuo, SC | 1 |
| Chang, NW | 3 |
| Yang, JS | 1 |
| Jan, CI | 1 |
| Huang, YP | 1 |
| Liu, CJ | 1 |
| Lin, C | 1 |
| Hsu, HT | 1 |
| Chu, PY | 1 |
| Yeh, CM | 1 |
| Yeh, KT | 1 |
4 other studies available for fenofibrate and Mouth Neoplasms
| Article | Year |
|---|---|
Fenofibrate diminishes the self-renewal and metastasis potentials of oral carcinoma stem cells through NF-κB signaling.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Fenofibrat | 2022 |
AMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-κB pathway.
Topics: AMP-Activated Protein Kinases; Cell Line, Tumor; Cell Movement; Fenofibrate; Humans; Hypolipidemic A | 2016 |
Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Pr | 2016 |
Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model.
Topics: 4-Nitroquinoline-1-oxide; Acetyl-CoA Carboxylase; Animals; Anticarcinogenic Agents; Arecoline; Carci | 2011 |